Skip to content

Clinical trials

Phase 2 Carcinoma, Ovarian Epithelial trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 2 Clear all

254 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
200115
20029
20038
200416
200514
200617
200722
20086
20096
20109
20116
20125
20136
20144
20154
20166
20172
20181
20192
20205
20219
20227
20234
20244
20252
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed146
Terminated39
Unknown status37
Recruiting10
Active, not recruiting10
Withdrawn7
Not yet recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)34
Gynecologic Oncology Group23
Memorial Sloan Kettering Cancer Center9
Fred Hutchinson Cancer Center8
Masonic Cancer Center, University of Minnesota6
M.D. Anderson Cancer Center4
NYU Langone Health4
SWOG Cancer Research Network4
AGO Study Group3
Cancer Research UK3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial254
Ovarian Neoplasms158
Fallopian Tube Neoplasms106
Breast Neoplasms18
Recurrence14
Uterine Cervical Neoplasms14
Burkitt Lymphoma13
Hodgkin Disease13
Leukemia, Lymphocytic, Chronic, B-Cell13
Lymphoma, B-Cell, Marginal Zone13

Trials

Showing 51 to 75 of 254. Each trial links to its page on Pharma Observatory.

154 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.